GDF-15 prevents platelet integrin activation and thrombus formation
GDF-15 prevents platelet integrin activation and thrombus formation
复制标题
DOI:
10.1111/jth.12100
复制
发表时间:
2013-02-01
影响因子:
10.4
通讯作者:
Zarbock, A.
中科院分区:
文献类型:
--
作者:
Rossaint, J.;Vestweber, D.;Zarbock, A.
Background Integrin-mediated platelet function plays an important role in primary hemostasis. Growth-differentiation factor 15 (GDF-15) has been shown to inhibit 2-integrin activation in leukocytes. Methods We investigated the effect of GDF-15 on platelet integrin activation in vitro and in different in vivo models of thrombus formation. Results GDF-15-/- mice showed an accelerated thrombus formation and a reduced survival rate after collagen-induced pulmonary thromboembolism. In reconstitution experiments, recombinant GDF-15 decelerated thrombus formation and prolonged the bleeding time. In vitro experiments demonstrated that GDF-15 pretreated, agonist-stimulated platelets showed decreased binding to fibrinogen in flow chamber assays and reduced activation of 1- and 3-integrins in flow cytometry experiments. Pretreating human and mouse platelets with GDF-15 reduced platelet aggregation. Mechanistically, GDF-15 prevents agonist-induced Rap1- dependent IIb3 activation by activating PKA. Platelet P-selectin expression and dense granule secretion after stimulation were unaffected by GDF-15, indicating a specific effect of GDF-15 on integrin activation. Conclusion GDF-15 specifically inhibits platelet integrin activation. These findings may have profound clinical implications for the treatment of hemostatic conditions involving platelets.